Show Menu

A fully integrated developer and manufacturer of polyclonal therapeutics, targeting infectious disease and acute toxic events

News: Archive for January 2018

Acquisition of Sanofi Pasteur’s Equine Antivenom Immunoglobulin Products

MicroPharm Limited is pleased to announce the acquisition of Sanofi Pasteur’s antivenom equine immunoglobulin product range comprising Viperfav®, Bothrofav® Scorpifav®, Fav-Afrique® and Favirept®.

Read the full story

Posted on: Tuesday, 2nd January 2018